Zhejiang Huazhou Pharmaceutical Co., Ltd. – FDA Inspection, Mar 22, 2018

Record Details

This FDA Inspection record concerns Zhejiang Huazhou Pharmaceutical Co., Ltd., with an inspection on March 22, 2018, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Zhejiang Huazhou Pharmaceutical Co., Ltd.
Inspection Date: March 22, 2018
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Christopher T. Middendorf (FDA Associated Person)

View Company Profile

ID · 9415fa8a-88ac-47fa-87d0-ef8a1bfe2b3e

Inspection Facts

Inspection number: 1045605
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Zhejiang Huazhou Pharmaceutical Co., Ltd.

FDA Inspection

Zhejiang Huazhou Pharmaceutical Co., Ltd.March 22, 2018

Zhejiang Huazhou Pharmaceutical Co., Ltd. – FDA Inspection, Mar 22, 2018

Record Details

This FDA Inspection record concerns Zhejiang Huazhou Pharmaceutical Co., Ltd., with an inspection on March 22, 2018, issued by the Office of Inspections and Investigations, covering human drugs.